Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.


Date Title Topic
06 Sep 2019 Treatment of Gynaecologic Malignancies During Pregnancy Gynaecologic malignancies - Cancer in Special Situations / Population
05 Sep 2019 Menopausal Hormone Therapy Starting at Age 50 Years Increases Breast Cancer Incidence in Women of Average Weight in Developed Countries Breast cancer - Epidemiology/Etiology/Cancer Prevention
26 Aug 2019 Increased Risk for Cardiovascular Diseases in Survivors of Adult Cancers Epidemiology/Etiology/Cancer Prevention
23 Aug 2019 EMA/FDA Analysis Shows High Degree of Alignment in Marketing Application Decisions Between EU and US Bioethics, legal and economic issues
22 Aug 2019 A Subset of Patients Develops Off-Target Mechanisms of Resistance to TRK Inhibition Personalised medicine
21 Aug 2019 FDA Approves Fedratinib for Myelofibrosis Haematologic malignancies - Anticancer agents & Biologic therapy
20 Aug 2019 FDA Approves Entrectinib for the Treatment of NTRK Fusion-Positive Solid Tumours in Adult and Adolescent Patients Lung and other thoracic tumours - Cancer in Special Situations / Population - Personalised medicine
19 Aug 2019 Communication Between AYA Cancer Patients and Healthcare Professionals Through Digital Media: Handle With Care! Cancer in Special Situations / Population
14 Aug 2019 Genomic Medicine Transforms Healthcare Personalised medicine
13 Aug 2019 FDA Approves Pexidartinib for Tenosynovial Giant Cell Tumour Sarcomas - Anticancer agents & Biologic therapy
12 Aug 2019 Robust Evidence Supports Off-label Recommendations in the NCCN Guidelines Anticancer agents & Biologic therapy
12 Aug 2019 Names of Liposomal Medicines To Be Changed to Avoid Medication Errors Bioethics, legal and economic issues
09 Aug 2019 FDA Approves Darolutamide for Non-metastatic Castration-resistant Prostate Cancer Genitourinary cancers - Anticancer agents & Biologic therapy
08 Aug 2019 FDA Approves Pembrolizumab for Advanced Oesophageal Squamous Cell Cancer Gastrointestinal cancers - Cancer Immunology and Immunotherapy
07 Aug 2019 T Cell Response to Immune Checkpoint Blockade Characterised Cancer Immunology and Immunotherapy